Skip to main content
NCBI home page
Cancer Immunology, Immunotherapy : CII logoLink to Cancer Immunology, Immunotherapy : CII
. 1982 Aug;13(2):145–148. doi: 10.1007/BF00205316

Antitumor effect of heat-killed Aspergillus fumigatus mycelium in a mouse model

Jean B deKernion 1,✉, Laszlo Lovrekovich 2
PMCID: PMC11039283  PMID: 6760960

Abstract

A suspension of heat-killed Aspergillus fumigatus mycelium inhibited the growth of a chemically-induced mouse bladder tumor (MBT). Tumor growth was inhibited when the mycelium was injected into mice in a mixture with the tumor cells, when injected into growing tumors, and when introduced IP at the time tumor cells were injected into the hind leg muscle. In the concentrations that affected tumor growth no toxicity of the fungus preparation was observed. The fungal suspension was more effective against MBT than a Corynebacterium parvum strain known to be a potent biologic response modifier. A significant increase in the number of mouse peritoneal exudate cells (PEC) was noted following inoculation with the mycelium. The induced PEC were cytotoxic to the tumor cells in vivo, suggesting that at least part of the tumor inhibition by the mycelium is host-mediated.

Keywords: Tumor Cell, Mouse Model, Tumor Growth, Antitumor Effect, Biologic Response

References

  • 1.Basic I, Milas L, Grdina DJ, Withers HR. Destruction of hamster ovarian cell cultures by peritoneal macrophages from mice treated with Corynebacterium granulosum . J Natl Cancer Inst. 1974;52:1839. doi: 10.1093/jnci/52.6.1839. [DOI] [PubMed] [Google Scholar]
  • 2.Basic I, Milas L, Grdina DJ, Withers HR. In vitro destruction of tumor cells by macrophages from mice treated with Corynebacterium granulosum . J Natl Cancer Inst. 1975;55:589. doi: 10.1093/jnci/55.3.589. [DOI] [PubMed] [Google Scholar]
  • 3.Cassone A, Marconi P, Bistoni F, Mattia E, Sbaraglia G, Garaci E, Bonmassar E. Immunoadjuvant effects of Candida albicans and its cell wall fractions in a mouse lymphoma model. Cancer Immunol Immunother. 1981;10:181. [Google Scholar]
  • 4.Chirigos MA. Glucan. In: Chirigos MA, editor. Immune modulation and control of neoplasia by adjuvant therapy. New York: Raven Press; 1978. pp. 171–280. [Google Scholar]
  • 5.Cochran AJ. Man, cancer and immunity. London New York San Francisco: Academic Press; 1978. Immunotherapy; p. 160. [Google Scholar]
  • 6.Cook JA, Taylor D, Cohen C, Rodrigue J, Malshet V, Di Luzio NR. Comparative evaluation of the role of macrophages and lymphocytes in mediating the antitumor action of glucan. Prog Cancer Res Ther. 1978;7:183. [Google Scholar]
  • 7.Currie G. Cancer and the immune response. Chicago: Year Book Medical Publishers; 1980. Non-specific active immunotherapy; p. 97. [Google Scholar]
  • 8.deKernion J, Ramming K, Fraser K (1977) Immunotherapy and chemoimmunotherapy of FANFT bladder tumor. AACR Abstracts 462
  • 9.deKernion JB, Ramming KP, Fraser K. A bladder-tumor model response to immunotherapy. Natl Cancer Inst Monogr. 1978;49:333. [PubMed] [Google Scholar]
  • 10.Di Luzio NR, Williams DL, McNamee RB, Edwards BF, Kitahama A. Comparative tumor-inhibitory and anti-bacterial activity of soluble and particulate glucan. Int J Cancer. 1979;24:773. doi: 10.1002/ijc.2910240613. [DOI] [PubMed] [Google Scholar]
  • 11.Foster RS., Jr Granulocyte and macrophage proliferation after injection of antitumor active and inactive strains of Corynebacterium parvum . Cancer Immunol Immunother. 1979;5:235. [Google Scholar]
  • 12.Gabizon A, Lelbovich SJ, Goldman R. Contrasting effects of activated and nonactivated macrophages and macrophages from tumor-bearing mice on tumor growth in vivo. J Natl Cancer Inst. 1980;65:913. [PubMed] [Google Scholar]
  • 13.Israel L. Report of 414 cases of human tumors treated with Corynebacteria. In: Halpern B, editor. Corybacterium parvum. Applications in experimental and clinical oncology. New York: Plenum Press; 1975. p. 389. [Google Scholar]
  • 14.Israel L, Edelstein R, Depierre A, Dimitrov N. Daily intravenous infusions of Corynebacterium parvum in twenty patients with disseminated cancer: A preliminary report of clinical and biologic findings. (Brief communication) J Natl Cancer Inst. 1975;55:29. doi: 10.1093/jnci/55.1.29. [DOI] [PubMed] [Google Scholar]
  • 15.Kawase I, Uemiya M, Yoshimoto T, Ogura T, Hirao F, Yamamura Y. Effect of Nocardia rubra cell wall skeleton on T-cell-mediated cytotoxicity in mice bearing syngeneic sarcoma. Cancer Res. 1981;41:660. [PubMed] [Google Scholar]
  • 16.Keller R. Abrogation of antitumor effects of Corynebacterium parvum and BCG by antimacrophage agents. (Brief communication) J Natl Cancer Inst. 1977;59:1751. doi: 10.1093/jnci/59.6.1751. [DOI] [PubMed] [Google Scholar]
  • 17.Mankowski ZT, Diller IC, Fisher ME. The effect of various fungi on mouse tumors with special reference to sarcoma 37. Cancer Res. 1957;17:382. [PubMed] [Google Scholar]
  • 18.Matsumoto T, Takanohashi M, Okubo Y, Suzuku M, Suzuki S. Growth inhibitory activity of the d-mannan of Saccharomyces cerevisiae X2180-1A-5 mutant strain against mouse-implanted sarcoma 180 and Ehrlich-carcinoma solid tumor. Carbohydr Res. 1980;83:363. doi: 10.1016/s0008-6215(00)84548-6. [DOI] [PubMed] [Google Scholar]
  • 19.Reilly HC. Microbiology and cancer therapy: A review. Cancer Res. 1953;13:821. [PubMed] [Google Scholar]
  • 20.Reilly HC, Stock CC. Studies on a tumor-retarding agent produced by Aspergillus fumigatus . Cancer Res. 1951;11:366. [PubMed] [Google Scholar]
  • 21.Riveros-Moreno V, Ford A. Effect of periodate treatment and phenol extraction of C. parvum on its capacity to activate macrophages. Cancer Immunol Immunother. 1980;9:121. [Google Scholar]
  • 22.Saltarelli CG, Coppola CP. Inhibitory effects of Candida albicans extracellular polysaccharides on mouse sarcoma 180. J Surg Oncol. 1980;15:99. doi: 10.1002/jso.2930150115. [DOI] [PubMed] [Google Scholar]
  • 23.Sone S, Pollack VA, Fidler IJ. Direct activation of tumoricidal properties in rat alveolar macrophages by Nocardia rubra cell wall skeleton. Cancer Immunol Immunother. 1980;9:227. [Google Scholar]
  • 24.Sutemi O, Kumano N, Kurita K. Antitumor activity of the yeast mannan preparation in relation to the effect of chemical modification. Gan. 1972;63:365. [PubMed] [Google Scholar]
  • 25.Suzuki M, Matsumoto T, Mikami T, Suzuki S. Enhancing effect of a modified yeast mannan on the antitumor activity of mytomycin C. Gan. 1976;67:607. [PubMed] [Google Scholar]
  • 26.Weinberg JB, Hibbs JB. Enhanced macrophage tumoricidal activity and tumor suppression or regression caused by heat-killed Candida albicans . J Natl Cancer Inst. 1979;63:1273. [PubMed] [Google Scholar]
  • 27.Whistler RL, Bushway AA, Singh PP. Noncytotoxic antitumor polysaccharides. Adv Carbohydr Chem Biochem. 1976;32:235. doi: 10.1016/s0065-2318(08)60338-8. [DOI] [PubMed] [Google Scholar]
  • 28.Willmott N, Pimm MV, Baldwin RW. Quantitative comparison of three C. parvum strains for immunotherapy of transplanted rat tumours. Cancer Immunol Immunother. 1979;7:117. [Google Scholar]

Articles from Cancer Immunology, Immunotherapy : CII are provided here courtesy of Springer

RESOURCES